Regenosine Inc.
PrivateLast Round
Grant
Aug 5, 2024
Total Funding Raised
$2.7M
Company Overview
Regenosine Inc. is a biotechnology company developing a first-in-class, disease-modifying regenerative therapy for osteoarthritis utilizing a proprietary liposomal adenosine intraarticular injection.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2G
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regenosine Inc. Comps
Public and private peers based on sector, stage, and business model.
Regenosine Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 5, 2024 | ||||
| Grant | Feb 16, 2023 | ||||
| Grant | Aug 8, 2022 | ||||
| Grant | Sep 16, 2021 | ||||
| Grant | Mar 1, 2021 |
Key People
Founding team and executive leadership
Regenosine Inc. Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 5, 2024
$798K grant from National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Feb 16, 2023
$25K grant received from NJ Commission on Science, Innovation and Technology.
Regenosine Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Regenosine Inc.'s valuation, stock price, and market status.
